Financhill
Sell
34

HRI Quote, Financials, Valuation and Earnings

Last price:
$187.34
Seasonality move :
5.61%
Day range:
$181.25 - $191.20
52-week range:
$124.70 - $246.88
Dividend yield:
1.42%
P/E ratio:
15.32x
P/S ratio:
1.55x
P/B ratio:
3.60x
Volume:
524.2K
Avg. volume:
326.3K
1-year change:
29.46%
Market cap:
$5.3B
Revenue:
$3.3B
EPS (TTM):
$12.23
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $2B $1.8B $2.1B $2.7B $3.3B
Revenue Growth (YoY) 1.13% -10.89% 16.38% 32.18% 19.78%
 
Cost of Revenues $1.5B $1.3B $1.3B $1.7B $2.1B
Gross Profit $542.3M $526.6M $756M $1.1B $1.2B
Gross Profit Margin 27.13% 29.56% 36.47% 38.87% 37.26%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $294.8M $257.4M $310M $411M $448M
Other Inc / (Exp) -$64M -$20M -$1M -$3M $8M
Operating Expenses $294.8M $319.9M $378M $506M $560M
Operating Income $247.5M $206.7M $378M $559M $663M
 
Net Interest Expenses $119.9M $92.6M $86M $122M $224M
EBT. Incl. Unusual Items $63.6M $94.1M $291M $434M $447M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $16.1M $20.4M $67M $104M $100M
Net Income to Company $47.5M $73.7M $224M $330M $347M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $47.5M $73.7M $224M $330M $347M
 
Basic EPS (Cont. Ops) $1.66 $2.53 $7.57 $11.15 $12.18
Diluted EPS (Cont. Ops) $1.63 $2.51 $7.37 $10.92 $12.09
Weighted Average Basic Share $28.7M $29.1M $29.6M $29.6M $28.5M
Weighted Average Diluted Share $29.1M $29.4M $30.4M $30.2M $28.7M
 
EBITDA $653.6M $653.1M $865M $1.2B $1.4B
EBIT $183.5M $186.7M $377M $556M $671M
 
Revenue (Reported) $2B $1.8B $2.1B $2.7B $3.3B
Operating Income (Reported) $247.5M $206.7M $378M $559M $663M
Operating Income (Adjusted) $183.5M $186.7M $377M $556M $671M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $456.7M $550.4M $745M $908M $965M
Revenue Growth (YoY) -10.12% 20.52% 35.36% 21.88% 6.28%
 
Cost of Revenues $322M $334.5M $440M $561M $580M
Gross Profit $134.7M $215.9M $305M $347M $385M
Gross Profit Margin 29.49% 39.23% 40.94% 38.22% 39.9%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $61M $81.5M $112M $115M $123M
Other Inc / (Exp) $300K $100K -- $3M --
Operating Expenses $61M $98.5M $137M $144M $156M
Operating Income $73.7M $117.4M $168M $203M $229M
 
Net Interest Expenses $22.4M $21.4M $33M $60M $69M
EBT. Incl. Unusual Items $51.6M $96.1M $135M $146M $160M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $11.7M $23.8M $34M $33M $38M
Net Income to Company $39.9M $72.3M $101M $113M $122M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $39.9M $72.3M $101M $113M $122M
 
Basic EPS (Cont. Ops) $1.37 $2.44 $3.41 $3.99 $4.30
Diluted EPS (Cont. Ops) $1.35 $2.37 $3.36 $3.96 $4.28
Weighted Average Basic Share $29.2M $29.6M $29.7M $28.3M $28.4M
Weighted Average Diluted Share $29.5M $30.5M $30.2M $28.5M $28.5M
 
EBITDA $191.4M $240M $333M $402M $436M
EBIT $74M $117.5M $168M $206M $229M
 
Revenue (Reported) $456.7M $550.4M $745M $908M $965M
Operating Income (Reported) $73.7M $117.4M $168M $203M $229M
Operating Income (Adjusted) $74M $117.5M $168M $206M $229M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.8B $2B $2.5B $3.2B $3.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.3B $1.3B $1.6B $2B $2.1B
Gross Profit $479.3M $706.5M $970.3M $1.2B $1.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $261.2M $290.8M $387M $445M $474M
Other Inc / (Exp) -$72.2M -$5.9M $100K -$2M $7M
Operating Expenses $261.2M $370.3M $475.2M $554M $595M
Operating Income $218.1M $336.2M $495.1M $663M $705M
 
Net Interest Expenses $43.6M $86.3M $103.2M $203M $255M
EBT. Incl. Unusual Items $102.3M $244M $392M $458M $457M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $29M $56.2M $88.3M $104M $109M
Net Income to Company $73.3M $187.8M $303.7M $354M $348M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $73.3M $187.8M $303.7M $354M $348M
 
Basic EPS (Cont. Ops) $2.53 $6.37 $10.21 $12.31 $12.29
Diluted EPS (Cont. Ops) $2.49 $6.20 $10.02 $12.17 $12.23
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $618.6M $801.8M $1.1B $1.4B $1.5B
EBIT $145.9M $330.3M $495.2M $661M $712M
 
Revenue (Reported) $1.8B $2B $2.5B $3.2B $3.4B
Operating Income (Reported) $218.1M $336.2M $495.1M $663M $705M
Operating Income (Adjusted) $145.9M $330.3M $495.2M $661M $712M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.3B $1.5B $2B $2.5B $2.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $939.9M $994.2M $1.2B $1.6B $1.6B
Gross Profit $321M $500.9M $747M $899M $976M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $187.6M $221M $298M $332M $358M
Other Inc / (Exp) -$14.2M -$100K $1M $2M $1M
Operating Expenses $187.6M $238M $367M $415M $450M
Operating Income $133.4M $262.9M $380M $484M $526M
 
Net Interest Expenses $70.1M $63.8M $81M $162M $193M
EBT. Incl. Unusual Items $49.1M $199M $300M $324M $334M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $10.9M $46.7M $68M $68M $77M
Net Income to Company $38.2M $152.3M $232M $256M $257M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $38.2M $152.3M $232M $256M $257M
 
Basic EPS (Cont. Ops) $1.31 $5.15 $7.79 $8.98 $9.06
Diluted EPS (Cont. Ops) $1.29 $5.01 $7.66 $8.90 $9.03
Weighted Average Basic Share $87.2M $88.7M $89.3M $85.7M $85.1M
Weighted Average Diluted Share $87.6M $91.1M $90.9M $86.5M $85.4M
 
EBITDA $469.9M $618.6M $839M $1B $1.1B
EBIT $119.2M $262.8M $381M $486M $527M
 
Revenue (Reported) $1.3B $1.5B $2B $2.5B $2.6B
Operating Income (Reported) $133.4M $262.9M $380M $484M $526M
Operating Income (Adjusted) $119.2M $262.8M $381M $486M $527M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $33M $33M $35.1M $54M $71M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $306.7M $301.2M $388.1M $523M $563M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $28.9M $32.9M $46.5M $67M $77M
Total Current Assets $399.7M $367.1M $469.7M $644M $732M
 
Property Plant And Equipment $3B $2.8B $3.4B $4.4B $5B
Long-Term Investments -- -- -- -- --
Goodwill $93.6M $100.5M $231.5M $419M $483M
Other Intangibles $291.5M $295.9M $388.7M $431M $467M
Other Long-Term Assets $23.1M $18.2M $13.1M $34M $418M
Total Assets $3.8B $3.6B $4.5B $6B $7.1B
 
Accounts Payable $126.5M $125.8M $280.6M $318M $212M
Accrued Expenses $72.4M $70.5M $82.3M $102M $106M
Current Portion Of Long-Term Debt $30.4M -- -- $16M $19M
Current Portion Of Capital Lease Obligations $30.5M $47.9M $53.9M $42M $37M
Other Current Liabilities -- -- -- -- $19M
Total Current Liabilities $323.1M $328M $529.9M $604M $508M
 
Long-Term Debt $2B $1.6B $1.9B $2.9B $3.6B
Capital Leases -- -- -- -- --
Total Liabilities $3.2B $2.8B $3.5B $4.8B $5.8B
 
Common Stock $300K $300K $300K -- --
Other Common Equity Adj -$109.7M -$107M -$100.2M -$129M -$118M
Common Equity $644.3M $742M $976.9M $1.1B $1.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $644.3M $742M $976.9M $1.1B $1.3B
 
Total Liabilities and Equity $3.8B $3.6B $4.5B $6B $7.1B
Cash and Short Terms $33M $33M $35.1M $54M $71M
Total Debt $2B $1.6B $1.9B $2.9B $3.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $53.8M $35.2M $56.9M $71M $142M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $293.3M $373.7M $519M $595M $623M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $37.9M $39.5M $58.8M $63M $66M
Total Current Assets $385M $448.4M $634.7M $729M $851M
 
Property Plant And Equipment $2.9B $3.2B $4.2B $5.1B $5.7B
Long-Term Investments -- -- -- -- --
Goodwill $93.6M $150.6M $379.1M $508M $659M
Other Intangibles $289.4M $349.2M $424.5M $468M $572M
Other Long-Term Assets $18.8M $15.7M $38.8M $55M $424M
Total Assets $3.7B $4.1B $5.7B $6.9B $8.2B
 
Accounts Payable $132.7M $201.8M $326.6M $247M $360M
Accrued Expenses $119.4M $172.8M $200.6M $230M $258M
Current Portion Of Long-Term Debt $17.7M $15.8M $11.2M $14M $15M
Current Portion Of Capital Lease Obligations $31.9M $36.3M $45.7M $47M $43M
Other Current Liabilities -- -- -- -- $21M
Total Current Liabilities $301.7M $426.7M $584.1M $538M $697M
 
Long-Term Debt $1.8B $1.8B $2.8B $3.7B $4.2B
Capital Leases -- -- -- -- --
Total Liabilities $3B $3.2B $4.6B $5.7B $6.7B
 
Common Stock $300K $300K $300K -- --
Other Common Equity Adj -$116.2M -$104.8M -$121.3M -$128M -$123M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $686.5M $909.2M $1.1B $1.2B $1.5B
 
Total Liabilities and Equity $3.7B $4.1B $5.7B $6.9B $8.2B
Cash and Short Terms $53.8M $35.2M $56.9M $71M $142M
Total Debt $1.8B $1.8B $2.8B $3.7B $4.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $47.5M $73.7M $224M $330M $347M
Depreciation & Amoritzation $470.1M $466.4M $488M $631M $755M
Stock-Based Compensation $19.5M $16.4M $23M $27M $18M
Change in Accounts Receivable -$38.3M -$24.6M -$92M -$172M -$98M
Change in Inventories -- -- -- -- --
Cash From Operations $635.6M $610.9M $743M $917M $1.1B
 
Capital Expenditures $695.3M $385.5M $641M $1.3B $1.5B
Cash Acquisitions -$4.2M -$21.1M -$431M -$515M -$430M
Cash From Investing -$463.6M -$207.5M -$960M -$1.7B -$1.6B
 
Dividends Paid (Ex Special Dividend) -- -- -$15M -$68M -$73M
Special Dividend Paid
Long-Term Debt Issued $2.4B $528M $1.1B $2.6B $2.1B
Long-Term Debt Repaid -$2.6B -$938.6M -$893M -$1.6B -$1.4B
Repurchase of Common Stock -- -- -- -$115M -$120M
Other Financing Activities -$45.2M -$3.3M -$9M -$23M -$26M
Cash From Financing -$167.1M -$406M $220M $785M $512M
 
Beginning Cash (CF) $27.8M $33M $33M $35M $54M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.9M -$2.6M $3M $20M $17M
Ending Cash (CF) $33M $33M $35M $54M $71M
 
Levered Free Cash Flow -$59.7M $225.4M $102M -$355M -$390M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $39.9M $72.3M $101M $113M $122M
Depreciation & Amoritzation $117.4M $122.5M $165M $196M $207M
Stock-Based Compensation $5.4M $5.5M $9M $6M $7M
Change in Accounts Receivable -$46.8M -$53.4M -$73M -$55M -$54M
Change in Inventories -- -- -- -- --
Cash From Operations $143.6M $175.3M $264M $280M $336M
 
Capital Expenditures $118.2M $217.9M $339M $439M $341M
Cash Acquisitions -- -$207.3M -$124M -$60M -$277M
Cash From Investing -$70M -$409.1M -$442M -$394M -$543M
 
Dividends Paid (Ex Special Dividend) -- -- -$17M -$18M -$19M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $85M $317.9M $1.2B $465M $690M
Long-Term Debt Repaid -$190M -$83M -$946M -$301M -$393M
Repurchase of Common Stock -- -- -$53M -- --
Other Financing Activities -$400K -$600K -$8M -- --
Cash From Financing -$103.4M $234.9M $184M $148M $279M
 
Beginning Cash (CF) $83.2M $34.6M $52M $37M $70M
Foreign Exchange Rate Adjustment $400K -$500K -$1M -- --
Additions / Reductions -$29.8M $1.1M $6M $34M $72M
Ending Cash (CF) $53.8M $35.2M $57M $71M $142M
 
Levered Free Cash Flow $25.4M -$42.6M -$75M -$159M -$5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $73.3M $187.8M $303.7M $354M $348M
Depreciation & Amoritzation $472.7M $471.5M $590.2M $736M $783M
Stock-Based Compensation $17.3M $24M $25.1M $22M $19M
Change in Accounts Receivable -$15.8M -$91.3M -$166.8M -$95M -$95M
Change in Inventories -- -- -- -- --
Cash From Operations $618.4M $690.1M $862.8M $1.1B $1.2B
 
Capital Expenditures $458.9M $558.4M $1.1B $1.6B $1.1B
Cash Acquisitions $11.1M -$261.6M -$646.8M -$406M -$665M
Cash From Investing -$259.5M -$649.7M -$1.7B -$1.7B -$1.5B
 
Dividends Paid (Ex Special Dividend) -- -- -$66M -$73M -$75M
Special Dividend Paid
Long-Term Debt Issued $568.7M $537.9M $2.7B $2.3B $2.7B
Long-Term Debt Repaid -$923M -$598.2M -$1.8B -$1.4B -$2.2B
Repurchase of Common Stock -- -- -$53M -$169M -$13M
Other Financing Activities $10.1M -$8.9M -$23.2M -$25M -$22M
Cash From Financing -$340.3M -$61M $823.1M $614M $387M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $18.6M -$20.6M $23.7M $14M $71M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $159.5M $131.7M -$223.1M -$478M $47M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $38.2M $152.3M $232M $256M $257M
Depreciation & Amoritzation $350.7M $355.8M $458M $563M $591M
Stock-Based Compensation $10.3M $17.9M $20M $15M $16M
Change in Accounts Receivable -$14.5M -$81.2M -$156M -$79M -$76M
Change in Inventories -- -- -- -- --
Cash From Operations $424M $503.2M $623M $796M $894M
 
Capital Expenditures $305.2M $478.1M $923M $1.2B $880M
Cash Acquisitions $15.3M -$225.2M -$441M -$332M -$567M
Cash From Investing -$171.6M -$613.8M -$1.3B -$1.3B -$1.2B
 
Dividends Paid (Ex Special Dividend) -- -- -$51M -$56M -$58M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $473M $482.9M $2.1B $1.8B $2.3B
Long-Term Debt Repaid -$705.1M -$364.7M -$1.2B -$1B -$1.8B
Repurchase of Common Stock -- -- -$53M -$107M --
Other Financing Activities -$3.2M -$8.8M -$23M -$25M -$21M
Cash From Financing -$232.1M $112.9M $716M $545M $420M
 
Beginning Cash (CF) $172M $100.5M $110M $131M $204M
Foreign Exchange Rate Adjustment $500K -$100K -$1M -- --
Additions / Reductions $20.3M $2.3M $23M $17M $71M
Ending Cash (CF) $192.8M $102.7M $132M $148M $275M
 
Levered Free Cash Flow $118.8M $25.1M -$300M -$423M $14M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.45% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 8.95% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 3.34% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock